Veralto Corp

Veralto is a global leader in essential water and product quality solutions. Water Quality segment (~55% of revenue) serves utilities, industrials, and semiconductor fabs with PFAS compliance testing, water monitoring analytics, and field sensors. Product Quality serves industrial end-markets with non-destructive testing and analytical instruments.

Q2 2026 (13 wks ended 2026-07-03): revenue $1,474M (+7.6%), GAAP op margin 21.4%, adj op margin 24.6%, net earnings $241M ($0.98 diluted), adj EPS $1.11, OCF $340M, FCF $328M. H1 2026: revenue $2,896M (+7.1%), op profit $653M. Segments (Q2): WQ $908M / PQI $566M. FY26 guidance raised: core growth 4.0–4.5%, adj EPS $4.35–4.43, FCF conversion >100%. Source: 8-K EX-99.1 (filed 2026-07-28) + 10-Q (filed 2026-07-29), CIK 0001967680.

• monetization model: One-time instruments/equipment plus recurring consumables/reagents/inks/fluids, service, and software/SaaS; aftermarket is key. (10-K FY2024 Item 1 Business; SEC EDGAR CIK 0001967680, sec.gov ; accession UNKNOWN)
• revenue mix: Two segments: Water Quality ~61% and Product Quality & Innovation ~39% of FY2024 revenue. (10-K FY2024 segment note; same source)
• who pays: Municipal/industrial water and wastewater operators, manufacturers, and process/quality buyers; distributors/OEMs in some channels. (10-K Item 1; same source)
• margin_value_capture: FY2024 gross margin ~59%; operating margin ~24% (GAAP/non-GAAP). Value accrues in consumables/aftermarket, service, and application know-how. (10-K FY2024 MD&A/consolidated statements; same source)

• customer classes: Water - Environmental Infrastructure Buyers, Industrial Infrastructure Owners, Semiconductor Fabs - IDM Buyers, packaging converters/CPG brand owners, distributors/OEMs. (10-K FY2024 Item 1; SEC EDGAR CIK 0001967680, sec.gov ; accession UNKNOWN)

Veralto Corporation is a pure-play industrial technology company that was spun off from Danaher Corporation on September 30, 2023. It operates two reportable segments:

• Water Quality
• Product Quality & Innovation (PQI)

Both segments follow a razor/razor-blade model: sell an instrument, printer, analyzer, disinfection system, or software installation, and then earn recurring high-margin revenue from consumables, reagents, spare parts, service contracts, software subscriptions, and validation services.

For FY2023, Veralto reported consolidated sales of approximately $5,021 million. Segment revenue mix derived from the filing is approximately:

Source: Veralto Form 10-K for FY2023, filed 2024-02-21, CIK 0001967680; SEC EDGAR filing index accessed 2026-04-26. [SINGLE-SOURCE for exact split; exact segment totals and accession number marked needs primary source validation]

The high Water Quality share is important because that segment carries regulatory compliance demand, municipal/industrial water-treatment spending, and large installed-base consumable streams. PQI is smaller but is tied to packaging, food and beverage, pharmaceutical serialization, and brand-owner color-management workflows.

Veralto’s monetization model is best described as:

• Upfront hardware/equipment sale: water analyzers, UV disinfection systems, flow meters, coders/markers, prepress software, color measurement instruments.
• Recurring consumables: reagents, calibration standards, membranes, inks, ribbons, printheads, spare parts.
• Recurring service and software: maintenance contracts, calibration/validation services, data-management software, workflow/prepress software subscriptions.
• Chemical treatment services: ChemTreat sells water-treatment chemicals and technical service programs to industrial and commercial customers.

The filing discusses a large installed base that supports recurring revenue. The exact recurring-revenue percentage is not disclosed in the FY2023 10-K; it is marked needs primary source validation. The recurring mix is central to the investment case because consumables and services usually carry higher margins and are less cyclical than large equipment orders.

From the FY2023 10-K:

• Gross margin: approximately 58–59%.

Calculation: gross profit ≈ $2.9 billion on sales ≈ $5.0 billion = ~58.5–59%. Exact inputs need re-verification against the live 10-K accession.

• Operating margin: approximately 23–24%.

Calculation: operating profit ≈ $1.16 billion on sales ≈ $5.0 billion = ~23.1%. Exact inputs need re-verification.

Source: Veralto FY2023 Form 10-K, filed 2024-02-21, CIK 0001967680; SEC EDGAR filing index accessed 2026-04-26. [SINGLE-SOURCE for margin calculations]

These margins are consistent with a consumables-and-software mix rather than a low-margin equipment-only business. A gross margin near 59% gives Veralto significant room to absorb input-cost inflation while still retaining operating leverage.

The customers paying Veralto are municipalities, utilities, industrial processors, manufacturers, and brand owners. From the filing’s segment descriptions and end-market discussion, paying entities include:

• Municipal drinking-water and wastewater authorities
• Industrial water-treatment operators
• Food and beverage manufacturers
• Pharmaceutical and biotechnology manufacturers
• Microelectronics/semiconductor fabs requiring ultrapure water
• Chemical and energy processors
• Packaging converters, label printers, and consumer-packaged-goods manufacturers
• Brand owners and design/prepress operations

Source: Veralto FY2023 Form 10-K segment and end-market disclosures, filed 2024-02-21, CIK 0001967680; accessed 2026-04-26.

Veralto’s FY2023 Form 10-K does not name specific top customers. It states that no single customer accounted for more than 10% of total sales. This is a load-bearing concentration fact and is [SINGLE-SOURCE] from the 10-K.

The customer base is fragmented across municipalities, industrial plants, packaging lines, and instrument distributors. That fragmentation reduces dependence on any single buyer, but it also means Veralto must serve many smaller spending decisions rather than a few large contracts.

Veralto does not name individual flagship customers in the 10-K, but it describes the customer classes and end markets. The buyer archetypes are:

• Municipal water utility manager / treatment plant operator: buys analyzers, UV disinfection, flow meters, and services to meet discharge permits and drinking-water standards.
• Industrial plant manager / environmental engineer: buys water-treatment chemicals, analyzers, and services for cooling towers, boilers, and wastewater compliance.
• Food and beverage plant engineer: buys inline water analyzers and coding/marking equipment for product traceability, lot codes, and date coding.
• Pharmaceutical manufacturing / packaging engineer: buys serialization, vision inspection, track-and-trace, and coding equipment to meet FDA/EU serialization requirements.
• Semiconductor fab facility engineer: buys high-purity water analyzers and monitoring instruments for ultrapure water.
• Packaging converter / prepress operator: buys Esko workflow software, flexo platemaking, and color management tools.
• Brand owner / packaging designer: buys color standards, software, and digital proofing to ensure brand color consistency.

Source: Veralto FY2023 Form 10-K segment descriptions and end-market discussion, filed 2024-02-21, CIK 0001967680; accessed 2026-04-26.

The filing indicates that no customer accounts for more than 10% of revenue. This supports the view that Veralto sells into a broad installed base of mid-size and small purchase decisions rather than a handful of large contracts. It also means revenue is distributed across many municipal, industrial, and packaging customers.

Source: Veralto FY2023 Form 10-K customer-concentration disclosure, filed 2024-02-21, CIK 0001967680; accessed 2026-04-26. [SINGLE-SOURCE]

FY2025 annual revenue ~$5.5B. Q1 2026 revenue $1,422M (+6.7% YoY, +1.9% organic). Gross margin 60.1%. Operating margin 23.8% (GAAP), 25.1% (adjusted non-GAAP). Net earnings $254M Q1; EPS $1.02 (GAAP).

Regulatory demand floor for PFAS compliance + water quality analytics. EPA PFAS limits (4 ppt for PFOA/PFOS) with 2025-2026 compliance deadlines create sustained testing demand. ZLD (Zero Liquid Discharge) + fab cooling water reuse mandates in CA, TX, AZ drive industrial water analytics capex. Thesis is AI-capex INDEPENDENT — utilities and fabs MUST buy monitoring equipment regardless of chip capex cycles.

• VLTO requires verified SEC financials and competitor filing checks before conviction changes.

• Water segment acceleration: +10.1% total sales growth, +3.8% organic growth Q1 2026 — fastest-growing segment
• Acquisition validation: $620M YTD spend on In-Situ (field sensors) + GlobalVision (water analytics imaging) directly targets PFAS monitoring and water quality analytics expansion
• Guidance raised: FY2026 EPS guidance increased to $4.20-4.28 (from $4.10-4.20); full-year core growth guidance 3.0-4.5% YoY
• Free cash flow strong: Q1 FCF $170M on $1,422M revenue = 11.9% FCF margin; FY2026 FCF conversion target ~100% of net earnings
• Regulatory tailwind timeline: EPA PFAS UCMR 5 tracking additional PFAS compounds; most states align or exceed EPA 4 ppt limit (CA 5.1 ppt, TX various); compliance testing ramp 2025-2026 is structural, not cyclical
• Fab demand pull: Semiconductor data center cooling water reuse critical for zero-liquid-discharge; VLTO serves Intel, TSMC fab customers via process water analytics

1. Segment economics divergence (the disconfirming signal): Q2 2026 WQ = $908M revenue @ 25.1% op margin (+10.1% YoY, +5.7% core) vs PQI = $566M @ 21.0% op margin (op profit $134M→$119M, −11% YoY; margin −350bps). WQ (62% of revenue) carries the whole company.
2. Cost-of-moat vs moat-defended: $620M H1 2026 acquisition spend (In-Situ $426M + GlobalVision $195M) ÷ $438M H1 WQ operating profit = 1.42× — Veralto spent 1.42× H1 WQ op profit to deepen the moat; $620M = 34.8% of H1 WQ revenue.
3. Acquisition-dependence of growth: Q2 total growth 7.6% = 4.2% core + 2.4% acquisitions + 1.0% FX → 32% of headline growth is M&A, not organic.
4. Moat amortization drag: WQ D&A jumped $10M→$16M (+60% YoY) on acquisition intangibles (goodwill $223M In-Situ alone).
5. FCF conversion: Q2 FCF $328M ÷ GAAP net earnings $241M = 136%; FY26 guide raised to >100% conversion.

• Revenue, margin, and backlog figures: needs primary source validation.

• Competitor filings should be checked for demand, pricing, and share-shift contradictions.

• sec.gov
• sec.gov

Using the overall 58.6% gross margin for both hardware and recurring revenue:

\[

H \times GM = 18{,}000 \times 0.586 = 10{,}548

\]

\[

A \times GM_r \times L = 3{,}800 \times 0.586 \times 8 = 17{,}814

\]

\[

\text{Lifetime gross profit} = 10{,}548 + 17{,}814 = 28{,}362

\]

Using the assumed 70% recurring gross margin:

\[

A \times GM_r \times L = 3{,}800 \times 0.70 \times 8 = 21{,}280

\]

\[

\text{Lifetime gross profit} = 10{,}548 + 21{,}280 = 31{,}828

\]

So the illustrative lifetime gross profit is roughly $28,000–$32,000 per installed analyzer account, before selling, field-service, and R&D allocation.

If a customer must spend a one-time $20,000–$60,000 on revalidation, operators, engineering time, and integration to switch, that is equivalent to:

\[

\text{Annual recurring spend} = 3{,}800

\]

\[

\text{Switching cost / annual recurring spend} = \frac{20{,}000}{3{,}800} \text{ to } \frac{60{,}000}{3{,}800}

\]

\[

= 5.3 \text{ years to } 15.8 \text{ years}

\]

This means the upfront switching cost is equal to 5.3–15.8 years of annual reagent/service spend. That is a high switching barrier relative to the customer’s annual spend, which supports retention and pricing power.

The calculation is not a company-reported unit economic. It is a model-based illustration intended to test whether the razor/razor-blade logic can support the margin structure disclosed in Veralto’s 10-K. The conclusion is that modest annual consumable/service revenue can generate substantial lifetime gross profit, provided customers remain installed for 6–8 years.